-
1 Comment
Cogstate Limited is currently in a long term uptrend where the price is trading 35.0% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Cogstate Limited's total revenue rose by 42.9% to $14M since the same quarter in the previous year.
Its net income has increased by 78.3% to $-448K since the same quarter in the previous year.
Finally, its free cash flow grew by 449.7% to $7M since the same quarter in the previous year.
Based on the above factors, Cogstate Limited gets an overall score of 5/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU000000CGS8 |
Sector | Healthcare |
Industry | Health Information Services |
Market Cap | 235M |
---|---|
PE Ratio | 19.64 |
Target Price | 1.5 |
Beta | -0.23 |
Dividend Yield | None |
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CGS.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025